Literature DB >> 10898152

Study of beta-blockers/beta-cyclodextrins inclusion complex by NMR, DSC, X-ray and SEM investigation.

R Ficarra1, P Ficarra, M R Di Bella, D Raneri, S Tommasini, M L Calabrò, M C Gamberini, C Rustichelli.   

Abstract

The formation of inclusion complexes between beta-cyclodextrin with the two beta-blockers, atenolol and celiprolol, have been studied in the aqueous environment and in the solid state by nuclear magnetic resonance (NMR) spectroscopy, X-ray, differential scanning calorimetry (DSC) and scanning electron microscopy (SEM) techniques. The magnitude of the chemical shifts of the interior and exterior beta-cyclodextrin protons in the presence of each beta-blocker indicated that these are included within the beta-cyclodextrin cavity. In aqueous solution they form 1:1 complexes. In the solid state the formation of the beta-cyclodextrin/atenolol (celiprolol) complexes is confirmed by X-ray, DSC and SEM, also employed to characterize pure substances and their physical mixtures.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10898152     DOI: 10.1016/s0731-7085(00)00261-2

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  4 in total

1.  Diclofenac-beta-cyclodextrin binary systems: physicochemical characterization and in vitro dissolution and diffusion studies.

Authors:  Maria Letizia Manca; Marco Zaru; Guido Ennas; Donatella Valenti; Chiara Sinico; Giuseppe Loy; Anna Maria Fadda
Journal:  AAPS PharmSciTech       Date:  2005-10-22       Impact factor: 3.246

2.  Gene-silencing effects of anti-survivin siRNA delivered by RGDV-functionalized nanodiamond carrier in the breast carcinoma cell line MCF-7.

Authors:  Yanzhao Bi; Yifan Zhang; Chunying Cui; Lulu Ren; Xueyun Jiang
Journal:  Int J Nanomedicine       Date:  2016-11-04

3.  Anti-HER2 functionalized graphene oxide as survivin-siRNA delivery carrier inhibits breast carcinoma growth in vitro and in vivo.

Authors:  Xiaoli Wang; Qi Sun; Chunying Cui; Jing Li; Yifan Wang
Journal:  Drug Des Devel Ther       Date:  2018-09-07       Impact factor: 4.162

4.  Genistein in 1:1 inclusion complexes with ramified cyclodextrins: theoretical, physicochemical and biological evaluation.

Authors:  Corina Danciu; Codruta Soica; Mircea Oltean; Stefana Avram; Florin Borcan; Erzsebet Csanyi; Rita Ambrus; Istvan Zupko; Delia Muntean; Cristina A Dehelean; Marius Craina; Ramona A Popovici
Journal:  Int J Mol Sci       Date:  2014-01-27       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.